We’re pleased to announce that we’ve published two notices of special interest (NOSI) calling for applications to PAR-19-313, Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional), that focus on research on women’s health (NOT-GM-21-056) and data sciences (NOT-GM-21-062).
These NOSIs highlight the Office of Research on Women’s Health’s interest in supporting a meritorious application on women’s health, and the Office of Data Science Strategy’s interest in supporting a meritorious application on data science relevant to biomedical research. Applications for these NOSIs must be submitted in response to and meet all eligibility criteria of PAR-19-313.
Application deadline: January 27, 2022
If you have questions about these NOSIs, please contact Crina Frincu (women’s health) or Lakshmi Matukumalli (data science).